AVALON GLOBOCARE CORP (AVCO)

US05344R1041 - Common Stock

0.5259  -0.1 (-16.52%)

After market: 0.601 +0.08 (+14.28%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to AVCO. AVCO was compared to 67 industry peers in the Real Estate Management & Development industry. AVCO has a bad profitability rating. Also its financial health evaluation is rather negative. AVCO has a expensive valuation and it also scores bad on growth.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AVCO has reported negative net income.
In the past year AVCO has reported a negative cash flow from operations.
AVCO had negative earnings in each of the past 5 years.
In the past 5 years AVCO always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -82.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -556.86%
PM (TTM) -600.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

AVCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVCO has more shares outstanding
AVCO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -7.78, we must say that AVCO is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 14.00 is on the high side and indicates that AVCO has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 14
Debt/FCF N/A
Altman-Z -7.78
ROIC/WACCN/A
WACC8.18%

2.3 Liquidity

AVCO has a Current Ratio of 0.23. This is a bad value and indicates that AVCO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.23 indicates that AVCO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.93% over the past year.
Looking at the last year, AVCO shows a small growth in Revenue. The Revenue has grown by 5.16% in the last year.
Measured over the past years, AVCO shows a quite strong growth in Revenue. The Revenue has been growing by 17.67% on average per year.
EPS 1Y (TTM)27.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.38%
Revenue 1Y (TTM)5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y17.67%
Revenue growth Q2Q3.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVALON GLOBOCARE CORP

NASDAQ:AVCO (11/9/2022, 7:00:00 PM)

After market: 0.601 +0.08 (+14.28%)

0.5259

-0.1 (-16.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap46.82M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.31%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -556.86%
PM (TTM) -600.07%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)27.93%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y